Oxford, United Kingdom

Graham McClorey

This inventor holds 6 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignees: United Kingdom Research and Innovation, Oxford University Innovation Ltd, Association Institut De Myologie. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Graham McClorey. Retrieved from https://idiyas.com/inventor/graham-mcclorey-o992omad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Graham McClorey: Innovator in Therapeutic Peptides

Introduction

Graham McClorey is a notable inventor based in Oxford, GB, recognized for his contributions to the field of therapeutic peptides. With a total of two patents to his name, McClorey has made significant strides in developing innovative treatments for genetic disorders, particularly muscular dystrophies.

Latest Patents

McClorey's latest patents include groundbreaking work on cell-penetrating peptides. This invention focuses on peptides that can penetrate cell membranes and their conjugates with therapeutic molecules. The application of these peptides is particularly relevant in treating genetic disorders, including Duchenne muscular dystrophy. Another significant patent involves a combined therapy for Duchenne muscular dystrophy, which utilizes antisense oligonucleotides and viral vectors to enhance treatment efficacy.

Career Highlights

Throughout his career, Graham McClorey has been associated with prominent organizations such as Oxford University Innovation Limited and United Kingdom Research and Innovation. His work in these institutions has facilitated advancements in research and development, particularly in the realm of genetic therapies.

Collaborations

McClorey has collaborated with esteemed colleagues, including Matthew Wood and Raquel Manzano. These partnerships have contributed to the successful development of his innovative therapeutic approaches, enhancing the potential for effective treatments for muscular dystrophies.

Conclusion

Graham McClorey stands

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…